Drug interactions
Insulin aspart + Linagliptin-metformin
Severity: Moderate
Insulin aspart and Linagliptin-metformin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Combining insulin with linagliptin and metformin has additive glucose-lowering effects. This is a common and intended combination, but hypoglycemia risk increases, particularly with the DPP-4 inhibitor plus insulin.
What this interaction means in plain words
Insulin aspart and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Insulin aspart belongs to Endocrine; Linagliptin-metformin belongs to Endocrine.
Why it happens
Additive pharmacodynamic glucose lowering via different pathways.
What to do
Monitor blood glucose and consider lowering the insulin dose when adding or intensifying oral agents. Educate patients on recognizing hypoglycemia.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Insulin aspart and Linagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Insulin aspart
Frequently asked questions
Can I take Insulin aspart with Linagliptin-metformin?
MediHelp rates the interaction as moderate. Insulin aspart and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Combining insulin with linagliptin and metformin has additive glucose-lowering effects. This is a common and intended combination, but hypoglycemia risk increases, particularly with the DPP-4 inhibitor plus insulin.
How serious is the interaction between Insulin aspart and Linagliptin-metformin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and consider lowering the insulin dose when adding or intensifying oral agents. Educate patients on recognizing hypoglycemia.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
